Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Hematologic and Immunologic Function and Patient Well-Being for the Phase III RESONATE TM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Blood (2014) 124 (21): 4696.

https://doi.org/10.1182/blood.V124.21.4696.4696

Published: 2014

Journal Articles

BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib

Dietrich Sascha, MD, Andreas Pircher, MD, Mindaugas Andrulis, MD, Elena Ellert, MD, Frédéric Peyrade, Clemens-Martin Wendtner, MD, George A Follows, Martin JS Dyer, Thomas Elter, MD, Robert Zeiser, Anita Gaehler, MD, Michael Herrmann, Michael Herold, MDPhD, Claire Dearden, MD, Hanno Glimm, MD, Michael Hallek, MD, Anthony D Ho, MD, Michael Steurer, Thorsten Zenz, MD

Blood (2014) 124 (21): 3634.

https://doi.org/10.1182/blood.V124.21.3634.3634

Published: 2014

Journal Articles

Autoimmune Hemolytic Anemia and Immune Mediated Thrombocytopenia in the Phase III RESONATE TM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Including a Case Report

Marco Montillo, MD, Susan O'Brien, MD, Alessandra Tedeschi, MD, Peter Hillmen, MB, ChB, PhD, Claire Dearden, MD, Devinder Gill, MD, Jennifer R. Brown, MD PhD, Jaqueline C. Barrientos, MD, Stephen Mulligan, MBBS, MD FRACP, FRCPA, Richard R. Furman, MD, Florence Cymbalista, MD, Clara Plascencia, Stephen Chang, PhD, Emily Hsu, PhD, Danelle F. James, MD MAS, John C. Byrd, MD

Blood (2014) 124 (21): 5654.

https://doi.org/10.1182/blood.V124.21.5654.5654

Published: 2014

Journal Articles

Deep-Sequencing Reveals the Molecular Landscape of Splenic Marginal Zone Lymphoma: Biological and Clinical Implications

Blood (2014) 124 (21): 76.

https://doi.org/10.1182/blood.V124.21.76.76

Published: 2014

Journal Articles

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Mary Gleeson, FRCPath, Eliza A Hawkes, MD, Clare Peckitt, MSc, Andrew Wotherspoon, FRCPath, Ayoma Attygalle, PhD, Bhupinder Sharma, MD, Yong Du, MD, Mark Ethell, MD, Michael Potter, PhD, Claire Dearden, MD, Alan Horwich, MD, Ian Chau, MD, David Cunningham, FMedSci

Blood (2014) 124 (21): 1719.

https://doi.org/10.1182/blood.V124.21.1719.1719

Published: 2014

Journal Articles

Immunoglobulin Gene Translocations Are Frequent in Unclassifiable CD5+ Small B-Cell Leukemias and in Particular, a Novel Subtype Characterised by t(14;19)(q32;q13) and Deregulation of BCL3 Is Described.

Alison Morilla, BSc, Paloma Martin, MD PhD, Toon Min, PhD, Ricardo Morilla, MSc, Ellen Remstein, MD, David Gonzalez, PhD, Claire Dearden, MD, Gareth J. Morgan, MD PhD, Estella Matutes

Blood (2007) 110 (11): 4230.

https://doi.org/10.1182/blood.V110.11.4230.4230

Published: 2007

Journal Articles

Final Report of the UKCLL02 Trial: A Phase II Study of Subcutaneous Alemtuzumab Plus Fludarabine in Patients with Fludarabine Refractory CLL (on Behalf of the NCRI CLL Trials Sub-Group).

Hazem A. Sayala, MD, Paul Moreton, MD, Richard A. Jones, PhD, Andy C. Rawstron, PhD, Sheila J. O’Connor, PhD, Paul Evans, PhD, Carter Anthony, MsC, Claire Dearden, MD, Estella Matutes, MD, PhD, Andrew R. Pettitt, MD, PhD, Daniel B. Kennedy, MD, Peter Hillmen, MD, PhD

Blood (2006) 108 (11): 34.

https://doi.org/10.1182/blood.V108.11.34.34

Published: 2006

Journal Articles

Combined aCGH and Mutational Analysis of CLL Patients with 17p Deletion.

Hannah C. Rudenko, MSc, Vasantha Brito-Babapulle, PhD, David Gonzalez, PhD, Pilar Martinez, MD, Paola E. Leone, PhD, Chris Jones, PhD, Tim Dexter, PhD, Kerry Fenwick, MSc, Alan Mackay, BSc, Alan Ashworth, PhD, Estella Matutes, MD, Daniel Catovsky, MD, Claire Dearden, MD, Gareth J. Morgan, MD,PhD

Blood (2006) 108 (11): 2091.

https://doi.org/10.1182/blood.V108.11.2091.2091

Published: 2006

Journal Articles

Comparison of IgH Gene Rearrangement Configuration between Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia Variant (HCL-v).

David Gonzalez, PhD, Ricardo Morilla, MSc, Alison Morilla, BSc, Monica Else, MSc, Nnenna Osuji, MD, Daniel Catovsky, MD, Claire Dearden, MD, Gareth J. Morgan, MD, PhD, Estella Matutes, MD

Blood (2005) 106 (11): 4997.

https://doi.org/10.1182/blood.V106.11.4997.4997

Published: 2005

Journal Articles

Bacterial Artificial Chromosome (BAC) Array CGH Study of B-CLL Patients with 17p13 Deletion.

Vasantha Brito-Babapulle, PhD, Hannah Rudenko, MSc, Claire Dearden, MD, Kerry Fenwick, BSc, Alan Mckay, BSc, Alan Ashworth, PhD, Estella Matutes, MD, Daniel Catovsky, MD, Gareth Morgan, MD

Blood (2005) 106 (11): 2110.

https://doi.org/10.1182/blood.V106.11.2110.2110

Published: 2005

Journal Articles

Combinations of ZAP-70, CD38 and IgVH Mutational Status as Predictors of Time to First Treatment in CLL.

Alison Morilla, BSc, David Gonzalez, PhD, Ilaria Del Giudice, MD, Ricardo Morilla, MSc, Estella Matutes, MD, Claire Dearden, MD, Daniel Catovsky, MD, Gareth Morgan, PhD

Blood (2005) 106 (11): 711.

https://doi.org/10.1182/blood.V106.11.711.711

Published: 2005

Journal Articles

High Incidence of Myelodysplasia and Secondary Leukemia in the UK MRC Pilot Study of Autografting in Chronic Lymphocytic Leukemia.

Donald Milligan, MD, FRCP, Geothy Kochethu, MD, Claire Dearden, MD, Estella Matutes, MD, Christopher MacConkey, PhD, Daniel Catovsky, DSc

Blood (2005) 106 (11): 153.

https://doi.org/10.1182/blood.V106.11.153.153

Published: 2005

Journal Articles

B- Cell Chronic Lymphocytic Leukaemia Complicated by Aggressive T-Cell Lymphoma: Clinical and Molecular Analysis of a Rare Variant of Richter’s Syndrome.

Ferdinandos Skoulidis, MRCP, Kevin Boyd, MRCP, David Cunningham, MD, FRCP, Andrew Wotherspoon, MRCPath, David Gonzalez, PhD, Daniel Catovsky, MD, FRCP, FRCPath, Gareth Morgan, FRCP, PhD, FRCPath, Estella Matutes, MD, PhD, Claire Dearden, MD, FRCP, MRCPath

Blood (2005) 106 (11): 4999.

https://doi.org/10.1182/blood.V106.11.4999.4999

Published: 2005

Journal Articles

Response to Therapy and Survival in CLL Is Influenced by Genetic Markers. Preliminary Analysis from the LRF CLL4 Trial.

Daniel Catovsky, MD, DSc, Sue Richards, PhD, Estella Matutes, Anna Burford, BSc, Vasantha Brito-Babapulle, PhD, Claire Dearden, MD, Philip Morris, PhD, Andrew Pettitt, PhD, MRCPath

Blood (2004) 104 (11): 13.

https://doi.org/10.1182/blood.V104.11.13.13

Published: 2004

NARROW

Hematologic and Immunologic Function and Patient Well-Being for the Phase III RESONATE TM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib

Autoimmune Hemolytic Anemia and Immune Mediated Thrombocytopenia in the Phase III RESONATE TM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Including a Case Report

Deep-Sequencing Reveals the Molecular Landscape of Splenic Marginal Zone Lymphoma: Biological and Clinical Implications

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Immunoglobulin Gene Translocations Are Frequent in Unclassifiable CD5+ Small B-Cell Leukemias and in Particular, a Novel Subtype Characterised by t(14;19)(q32;q13) and Deregulation of BCL3 Is Described.

Final Report of the UKCLL02 Trial: A Phase II Study of Subcutaneous Alemtuzumab Plus Fludarabine in Patients with Fludarabine Refractory CLL (on Behalf of the NCRI CLL Trials Sub-Group).

Combined aCGH and Mutational Analysis of CLL Patients with 17p Deletion.

Comparison of IgH Gene Rearrangement Configuration between Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia Variant (HCL-v).

Bacterial Artificial Chromosome (BAC) Array CGH Study of B-CLL Patients with 17p13 Deletion.

Combinations of ZAP-70, CD38 and IgVH Mutational Status as Predictors of Time to First Treatment in CLL.

High Incidence of Myelodysplasia and Secondary Leukemia in the UK MRC Pilot Study of Autografting in Chronic Lymphocytic Leukemia.

B- Cell Chronic Lymphocytic Leukaemia Complicated by Aggressive T-Cell Lymphoma: Clinical and Molecular Analysis of a Rare Variant of Richter’s Syndrome.

Response to Therapy and Survival in CLL Is Influenced by Genetic Markers. Preliminary Analysis from the LRF CLL4 Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only